Latest Breaking News On - Evariste cagatan - Page 4 : vimarsana.com
VAX MAKER. Yisheng Biopharma Co. Ltd. chairman Zhang Yi (5th from left) meets with officials of the Board of Investments to discuss the company's investment plans in the country. Yisheng is also looking for potential local partners to operate in the Philippines. (Photo courtesy of BOI) MANILA - The Board of Investments (BOI) said Tuesday the agency met with Chinese global pharmaceutical firm Yisheng Biopharma Co. Ltd. to discuss the company's investment plans in the Philippines. Yisheng chairman Zhang Yi led the business delegation to Manila as the group also met with possible local partners here. The Chinese pharmaceutical firm is engaged in the development and commercialization of biotherapeutics for cancers and infectious diseases through its novel PIKA immunomodulation technology. The firm is operating in China, Singapore, and the United States. "In the meeting, Chairman Yi and the Yisheng team shared that the company is preparing to initiate Phase III [of its] global
ChinaYishengZhejiangManilaPhilippinesUnited-statesZhang-yiNingxiaSingaporeChineseEvariste-cagatanCorazon-halili-dichosa